Clinically Validated and FDA-Approved for the Treatment of Heavy Menstrual Bleeding
Minitouch is a third-generation endometrial ablation system, FDA-approved for the treatment of heavy menstrual bleeding (HMB) in premenopausal women who are finished with childbearing. Designed for maximum safety and effectiveness, it provides a gentle, minimally invasive alternative to hysterectomy and other surgical treatments.
Indications for Use
Minitouch is indicated for:
Premenopausal women with heavy menstrual bleeding (menorrhagia) due to benign causes
Patients who do not wish to undergo major surgery such as hysterectomy
Women who are seeking an in-office, minimally invasive treatment
Patients with normal uterine anatomy, including those with prior C-sections or irregular uterine cavities
By integrating smoothly into any practice, Minitouch helps increase patient volume, maximize revenue, and enhance care delivery.
Contraindications
Minitouch is not recommended for patients who:
Are pregnant or desire future fertility
Have an active genital, pelvic, or uterine infection
Have suspected or diagnosed endometrial cancer or hyperplasia
Have significant uterine abnormalities, such as fibroids that distort the uterine cavity
Have an intrauterine device (IUD) in place
Physicians should carefully screen candidates to ensure optimal patient selection and safety.
Common Side Effects
Minitouch is a well-tolerated procedure, with most patients reporting minimal discomfort. Some common, temporary side effects m
01
Mild cramping
(typically resolves within hours)
02
Light spotting
or watery discharge (lasting a few days to weeks)
03
Temporary changes
changes in menstrual cycles before full results are achieved
These effects are generally mild and require little to no intervention. Most patients resume normal activities within 24 hours.
Potential Adverse Events
Serious complications with Minitouch are rare, but as with any medical procedure, potential risks include:
Clinical studies have shown no major adverse events, no device failures, and no severe complications.
Patients must use reliable contraception following treatment
Tubal ligation, IUDs (placed after healing), or other forms of birth control should be discussed
Minitouch is not a sterilization procedure—it is essential that patients understand pregnancy risks post-ablation
Contraception Required After Treatment
Pregnancy is not recommended after endometrial ablation as the uterine lining is permanently altered, increasing risks for complications.
Minitouch is a clinically proven, FDA-approved
treatment for heavy menstrual bleeding, offering a safe, minimally invasive solution with long-term results and minimal risk.